A migraine can feel like a hammer pounding on the side of your head, relentless and unyielding. The pain is sharp and throbbing, often paired with waves of nausea that make it hard to think clearly. Bright lights seem blinding, and even the slightest noise feels amplified, making everything around you feel unbearably intense.
For many, finding reliable relief can be a constant struggle. Ubrogepant is a medication that may help relieve symptoms associated with migraines.
This article discusses its potential side effects, long-term safety, and effectiveness.
[signup]
Understanding Ubrogepant
Ubrogepant is a newer treatment option for those experiencing acute migraine attacks. Let's take a look at what it is and how it works compared to traditional treatments.
What is Ubrogepant?
Ubrogepant (Ubrelvy) is an oral medication used to help relieve symptoms during a migraine attack. It belongs to a class of drugs known as calcitonin gene-related peptide (CGRP) antagonists. Unlike medications that are used to prevent migraines, ubrogepant is intended for acute use, meaning it is taken after a migraine starts to help reduce symptoms.
It is FDA-approved for the acute treatment of migraines, with or without aura, in adults, though it does not address the root causes.
How Ubrogepant Works
Ubrogepant works by blocking CGRP, a substance in the brain involved in migraine pain and inflammation. During a migraine, CGRP levels rise, which can trigger pain and other symptoms.
By preventing CGRP from binding to its receptors, ubrogepant may help interrupt this process and reduce migraine severity. However, its effectiveness can vary.
Ubrogepant vs. Traditional Migraine Treatments
Traditional migraine treatments, like triptans (e.g., sumatriptan), reduce pain by narrowing blood vessels. However, these medications may not be suitable for individuals with cardiovascular conditions, as narrowing blood vessels can put extra strain on the heart. This could increase the risk of heart-related concerns, particularly in those with high blood pressure, heart disease, or a history of stroke.
Ubrogepant works differently by blocking CGRP rather than affecting blood vessels, making it a potential option for individuals who cannot use triptans or those with certain health conditions. However, the decision to use ubrogepant should be made in consultation with a healthcare provider based on individual health needs.
Ubrogepant is not a substitute for preventive migraine treatments. It is meant to help manage acute attacks and should be part of a broader treatment plan that includes strategies for long-term relief.
Side Effects of Ubrogepant
Ubrogepant may cause side effects that can vary between individuals. The most common side effects are generally mild to moderate and may include:
- Nausea
- Tiredness or fatigue
- Dry mouth
- Dizziness (especially when standing up quickly)
- Drowsiness (somnolence)
These effects may resolve on their own, but if they persist or worsen, contact your healthcare provider.
When To Call Your Doctor
In rare cases, serious side effects may occur. Contact your healthcare provider if side effects persist or interfere with your daily activities. However, if you experience any of the following, seek immediate medical attention:
- Allergic reactions, such as rash, itching, swelling, or difficulty breathing
- Severe dizziness that affects your ability to function
- Unusual abdominal pain or discomfort
- Chest pain, especially with shortness of breath or other heart-related symptoms
Ubrogepant may affect liver health, particularly in individuals with preexisting liver conditions. Your doctor may monitor your liver function during treatment. If you notice symptoms like jaundice (yellowing of the skin or eyes) or dark urine, contact your healthcare provider promptly.
Factors Influencing Side Effects
Several factors can affect how ubrogepant works and its potential side effects:
- Dosage: Follow your healthcare provider's instructions and avoid exceeding the recommended dose.
- Health History: Your age, overall health, and medical history can impact your response to ubrogepant.
- Pregnancy and Breastfeeding: If you are pregnant, planning to become pregnant, or breastfeeding, consult your healthcare provider. The safety of ubrogepant during pregnancy and breastfeeding has not been fully established.
- Preexisting Conditions: Conditions like liver or kidney disease may affect how ubrogepant works. Inform your healthcare provider of any such conditions.
- Drug Interactions: Ubrogepant can interact with other medications, potentially altering its effectiveness or increasing the risk of side effects. Be sure to inform your provider about all medications, including over-the-counter OTC drugs, herbs, and supplements.
Managing Ubrogepant Side Effects
Side effects from ubrogepant can often be minimized or managed with proper preventive measures and treatment strategies.
Preventive Measures
To reduce the likelihood of side effects, follow the guidance of your healthcare provider. This includes taking the medication as prescribed and not exceeding the recommended dose. If you experience dizziness or drowsiness, your doctor may recommend avoiding activities like driving until you understand how ubrogepant affects you.
Staying hydrated and eating before taking ubrogepant can help minimize mild side effects like nausea and dry mouth. Additionally, managing stress and avoiding known migraine triggers may help reduce the frequency of migraines and the need for treatment.
Treatment Strategies
If side effects occur, simple strategies may help provide relief. Staying hydrated and resting can help with mild symptoms like nausea, drowsiness, or fatigue. To manage dizziness, move slowly between seated and standing positions. If dry mouth (xerostomia) is uncomfortable, drinking water or using saliva substitutes may help alleviate discomfort.
Ubrogepant Side Effects vs. Other CGRP Antagonists
Ubrogepant, rimegepant, and atogepant are CGRP antagonists used for migraine treatment. Though they all block the CGRP molecule, they have differences in their side effect profiles, safety, and intended uses. Speak with your healthcare provider to determine the best option for your needs.
Below is a comparison of their key aspects:
Comparison with Rimegepant
- Both medications are effective for acute migraine treatment.
- The most common side effects of both drugs include nausea, dizziness, and fatigue. However, studies suggest rimegepant may cause less drowsiness than ubrogepant.
- Rimegepant may be a better option for individuals with cardiovascular risk factors, as it does not affect blood pressure or heart rate like other treatments.
Both medications are well-tolerated, but individual responses may vary.
Comparison with Atogepant
- Atogepant can be used for both acute and preventive migraine treatment, while ubrogepant is primarily for acute treatment.
- Atogepant and ubrogepant share some side effects, including nausea, dry mouth, and fatigue. However, atogepant is associated with less drowsiness, making it a better option for those who need to avoid daytime sleepiness.
- Atogepant may be preferable for individuals who experience excessive drowsiness with ubrogepant.
Safety Profile in Clinical Trials
Clinical trials suggest that ubrogepant, rimegepant, and atogepant have favorable safety profiles. Most side effects are mild to moderate (e.g., nausea, dizziness, and fatigue) and typically resolve quickly.
All three medications are generally well-tolerated, though individual responses may vary. Consult your healthcare provider to choose the best option for your health needs and ensure any underlying conditions are considered before starting treatment.
Long-term Safety and Efficacy of Ubrogepant
When considering any medication, it's important to understand its immediate effects and its long-term safety and efficacy. One study compared the effectiveness of lasmiditan, rimegepant, and ubrogepant in treating migraines in patients who do not respond to triptans. This systematic review of five phase 3 trials with 3,004 patients found that all three medications were more effective than placebo in providing pain relief and symptom alleviation within two hours.
However, no significant differences in efficacy were observed between the medications. Overall, lasmiditan, rimegepant, and ubrogepant are all effective options for acute migraine treatment in triptan-insufficient responders.
In addition, a recent comprehensive evaluation of CGRP receptor antagonists assessed the safety and effectiveness of various treatments, including ubrogepant. Ubrogepant scored 70.37 points, ranking between eptinezumab (71.69) and zavegepant (56.44). These results further support that ubrogepant is an effective option for acute migraine treatment.
Current Research Findings
The PRODROME trial evaluated the benefits of ubrogepant for treating migraines during the prodrome phase (the early warning phase before a migraine headache begins). This randomized, double-blind, placebo-controlled study included 518 participants with moderate-to-severe migraines.
Participants received 100 mg of ubrogepant or a placebo during the prodrome phase. The study found that ubrogepant significantly improved participants' ability to function normally over 24 hours and reduced activity limitations compared to the placebo.
Additionally, participants treated with ubrogepant reported higher satisfaction levels at 8 and 24 hours post-treatment. These results suggest that ubrogepant 100 mg during the prodrome phase can effectively improve function and reduce activity limitations.
Ongoing Studies and Future Directions
Research indicates that the efficacy of CGRP receptor antagonists, such as ubrogepant and atogepant, may be similar in males and females, although the evidence for males is still limited.
Data from several randomized trials show comparable rates of pain freedom and symptom relief in both genders when treated with ubrogepant. Similarly, reductions in the number of migraine days were consistent across genders in trials of atogepant.
These findings suggest that both ubrogepant and atogepant may provide similar benefits for male and female patients. However, more research is needed to confirm these results and further explore the differences in treatment response.
Patient Monitoring and Follow-up
Even with ubrogepant's proven safety and efficacy, regular monitoring is essential.
Follow-up visits with your healthcare provider are essential for assessing how well the medication works and adjusting as needed. This is particularly important for individuals with underlying health conditions, such as liver or kidney disease, or those taking multiple medications.
If you experience any side effects or changes in your migraine pattern, be sure to discuss them with your healthcare provider.
Frequently Asked Questions (FAQs)
Here are answers to commonly asked questions about ubrogepant. Always consult your healthcare provider for personalized guidance based on your health needs and treatment plan.
What's the difference between preventive and acute migraine medications?
Preventive medications are taken regularly to reduce the frequency and severity of migraines, usually for those with frequent or chronic migraines. Acute medications like ubrogepant, however, are used as needed to relieve symptoms during an active migraine attack. Depending on individual needs and your healthcare provider's recommendations, both types may be part of a comprehensive treatment plan.
Can ubrogepant cause medication overuse headaches?
Medication overuse headaches (rebound headaches) can result from frequent use of acute migraine treatments. Ubrogepant is not typically linked to overuse headaches, but it should be used as prescribed. If you find that you are using ubrogepant frequently to manage migraines, consult your healthcare provider. They may recommend preventive treatments to reduce migraine frequency and improve overall management.
Are there any contraindications for using ubrogepant?
Ubrogepant may not be suitable for everyone. It should not be used by individuals with a known allergy to the medication or its ingredients. Those with severe liver disease should consult their healthcare provider before using ubrogepant, as liver function can impact how the medication is processed in the body. Be sure to inform your healthcare provider about your complete medical history to ensure ubrogepant is a safe and appropriate option for you.
How does ubrogepant affect pregnancy and breastfeeding?
The safety of ubrogepant during pregnancy and breastfeeding has not been fully established. If you are pregnant, planning to become pregnant, or breastfeeding, consult your healthcare provider to evaluate the risks and benefits for your specific situation. Your doctor may suggest alternative treatments that are safer during pregnancy or breastfeeding.
Can ubrogepant be used in combination with other migraine treatments?
Ubrogepant can be combined with other migraine treatments, but only under the guidance of your healthcare provider. If you're already using preventive migraine treatments, ubrogepant can be used for acute attacks. However, avoid overuse of multiple acute treatments, as this can lead to medication overuse headaches.
What should I do if I experience severe side effects from ubrogepant?
Most side effects of ubrogepant are mild and temporary. However, seek immediate medical attention if you experience symptoms such as chest pain, severe dizziness, difficulty breathing, or signs of an allergic reaction (rash, swelling, or difficulty breathing). For unusual or persistent side effects, contact your healthcare provider. Promptly report any adverse effects for proper evaluation and treatment adjustments.
[signup]
Key Takeaways
- Ubrogepant has shown effectiveness in providing relief from acute migraine symptoms, such as pain, nausea, and light sensitivity, especially for individuals who do not respond to traditional treatments like triptans. Most users tolerate it well, with mild side effects, including dizziness, nausea, and drowsiness.
- Regular follow-up with a healthcare provider is recommended to monitor its effectiveness and manage potential side effects. Treatment adjustments may be necessary for those with underlying health conditions or taking other medications.
- If you experience frequent migraines and haven't found relief with other medications, consider discussing ubrogepant with your doctor to see if it could be a suitable option for your treatment plan.
%201.svg){kind=logo}
